| 86R14405 SCL-F  
---|---  
|  By: Leman | H.B. No. 4213  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to abortion safety; authorizing an administrative  
| penalty.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 171.006(b), Health and Safety Code, as  
| added by Chapter 4 (H.B. 13), Acts of the 85th Legislature, 1st  
| Called Session, 2017, is amended to read as follows:  
|  (b) The reporting requirements of this section apply only  
| to:  
|  (1) a physician who:  
|  (A) performs at an abortion facility an abortion  
| that results in an abortion complication diagnosed or treated by  
| that physician; or  
|  (B) diagnoses or treats [ ~~at an abortion facility~~ ]  
| an abortion complication that is the result of an abortion  
| performed by another physician [ ~~at the facility~~ ]; or  
|  (2) a health care facility that is a hospital,  
| abortion facility, freestanding emergency medical care facility,  
| or health care facility that provides emergency medical care, as  
| defined by Section 773.003.  
|  SECTION 2. Subchapter A, Chapter 171, Health and Safety  
| Code, is amended by adding Section 171.008 to read as follows:  
|  _Sec._ ___171.008._ _____REQUIRED FOLLOW-UP APPOINTMENT. (a) A_  
| _physician who performs an abortion or gives, sells, dispenses,_  
| _administers, provides, or prescribes an abortion-inducing drug, as_  
| _defined by Section 171.061, or the physician's agent, must schedule_  
| _a follow-up appointment for the woman on a date not more than 14_  
| _days after the date of the abortion or administration or use of the_  
| _drug._ ___At the appointment, the physician must:_  
|  _(1)_ _____confirm the woman's pregnancy is completely_  
| _terminated; and_  
|  _(2) assess any continued blood loss._  
|  _(b)_ _____The Texas Medical Board may take disciplinary action_  
| _under Chapter 164, Occupations Code, or assess an administrative_  
| _penalty under Subchapter A, Chapter 165, Occupations Code, against_  
| _a physician who violates Subsection (a)._  
|  _(c)_ _____A penalty may not be assessed against a pregnant woman_  
| _who receives an abortion._  
|  SECTION 3. Section 171.061(3), Health and Safety Code, is  
| redesigned as Subdivision (8-a), Section 171.061, Health and Safety  
| Code, and amended to read as follows:  
|  _(8-a) "Printed_ [ ~~(3) "Final printed~~] label" [ ~~or "FPL"~~ ]  
| means the informational document approved by the United States Food  
| and Drug Administration for an abortion-inducing drug that:  
|  (A) outlines the protocol authorized by that  
| agency and agreed to by the drug company applying for authorization  
| of the drug by that agency; and  
|  (B) delineates how a drug is to be used according  
| to approval by that agency.  
|  SECTION 4. Sections 171.063(a), (d), and (f), Health and  
| Safety Code, are amended to read as follows:  
|  (a) A person may not knowingly give, sell, dispense,  
| administer, provide, or prescribe an abortion-inducing drug to a  
| pregnant woman for the purpose of inducing an abortion in the  
| pregnant woman or enabling another person to induce an abortion in  
| the pregnant woman unless:  
|  (1) the person who gives, sells, dispenses,  
| administers, provides, or prescribes the abortion-inducing drug is  
| a physician; and  
|  (2) except as otherwise provided by Subsection (b),  
| the provision, prescription, or administration of the  
| abortion-inducing drug satisfies the protocol tested and  
| authorized by the United States Food and Drug Administration as  
| outlined in the [ ~~final~~ ] printed label of the abortion-inducing drug  
| _as of January 1, 2019_.  
|  (d) The physician who gives, sells, dispenses, administers,  
| provides, or prescribes an abortion-inducing drug shall provide the  
| pregnant woman with:  
|  (1) a copy of the [ ~~final~~ ] printed label of that  
| abortion-inducing drug _as of January 1, 2019_ ; and  
|  (2) a telephone number by which the pregnant woman may  
| reach the physician, or other health care personnel employed by the  
| physician or by the facility at which the abortion was performed  
| with access to the woman's relevant medical records, 24 hours a day  
| to request assistance for any complications that arise from the  
| administration or use of the drug or ask health-related questions  
| regarding the administration or use of the drug.  
|  (f) The physician who gives, sells, dispenses, administers,  
| provides, or prescribes the abortion-inducing drug, or the  
| physician's agent, shall make a reasonable effort to ensure that  
| the woman returns for the scheduled follow-up _appointment_ [ ~~visit~~ ]  
| under _Section 171.008_ [ ~~Subsection (e)~~ ]. The physician or the  
| physician's agent shall document a brief description of any effort  
| made to comply with this subsection, including the date, time, and  
| name of the person making the effort, in the woman's medical record.  
|  SECTION 5. Section 171.063(e), Health and Safety Code, is  
| repealed.  
|  SECTION 6. The changes in law made by this Act apply only to  
| an abortion performed on or after the effective date of this Act.  
| An abortion performed before the effective date of this Act is  
| governed by the law in effect immediately before the effective date  
| of this Act, and that law is continued in effect for that purpose.  
|  SECTION 7. This Act takes effect September 1, 2019.

